| TPC | thromboplastic plasma component; thyroid papillary carcinoma; total patient care; total plasma catec... |
|---|---|
| IRMA | 1) Intra-Retinal Microvascular Abnormalities 2) Immuno-Radio-Metric Assay... |
| AGR | aniridia, genitourinary abnormalities, and mental retardation; anticipatory goal response |
| AUA | American Urological Association; asymptomatic urinary abnormalities |
| IRMA | immunoradiometric assay; intraretinal microvascular abnormalities |
| nervous system abnormalities | Congenital structural abnormalities of the nervous system. (12 Dec 1998) |
|---|---|
| stomatognathic system abnormalities | Congenital structural abnormalities of the mouth and jaws, including the dentition. (12 Dec 1998) |
| digestive system abnormalities | Congenital structural abnormalities of the digestive system. (12 Dec 1998) |
| tooth abnormalities | Congenital absence of or defects in structures of the teeth. (12 Dec 1998) |
| jaw abnormalities | Congenital absence of or defects in structures of the jaw. (12 Dec 1998) |
| eye abnormalities | Congenital absence of or defects in structures of the eye; may also be hereditary. (12 Dec 1998) |
| urogenital abnormalities | Congenital structural abnormalities of the urogenital system. (12 Dec 1998) |
| a1-lipoprotein | A lipoprotein fraction of relatively low molecular weight, high density, rich in phospholipids, and found in the a1-globulin fraction of human plasma. (05 Mar 2000) |
| b1-lipoprotein | A lipoprotein fraction of relatively high molecular weight, low density, rich in cholesterol, and found in the beta-globulin fraction of human plasma. (05 Mar 2000) |
| receptors, lipoprotein | Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognise the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis. (12 Dec 1998) |
| very low density lipoprotein | <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats (particularly triglycerides) in the bloodstream. Elevations in very low density lipoprotein in the bloodstream are associated with an increased risk of atherosclerosis and coronary artery disease. Acronym: VLDL (18 Nov 1997) |
| multiple lipoprotein-type hyperlipidaemia | <biochemistry> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides. There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease. Origin: Gr. Haima = blood (27 Sep 1997) |
| high density lipoprotein | <biochemistry> These lipoproteins acts to carry cholesterol in the bloodstream. Raised high density lipoprotein levels have been correlated with a lower risk for heart disease. Less than 35 mg/dl is considered a positive risk factor for coronary artery disease, over 60 mg/dl is considered a negative risk factor (reduces your risk of heart disease). Recent studies show a low high density lipoprotein level is the strongest predictor of cardiovascular death in women. Acronym: HDL (18 Nov 1997) |
| intermediate density lipoprotein | Class of lipoproteins formed in degradation of very-low-density lipoproteins; about half are cleared quickly from the plasma into the liver by receptor-mediated endocytosis; the other half are degraded into low density lipoproteins. (05 Mar 2000) |
| familial high density lipoprotein deficiency | Familial high {density lipoprotein deficiency}; a heritable disorder of lipid metabolism characterised by almost complete absence from plasma of high density lipoproteins, and by storage of cholesterol esters in foam cells, tonsillar enlargement, an orange or yellow-gray colour of the pharyngeal and rectal mucosa, hepatosplenomegaly, lymph node enlargement, corneal opacity, and peripheral neuropathy; autosomal recessive inheritance. Synonym: familial high {density lipoprotein deficiency}, Tangier disease. Origin: G. An-, priv., + alpha, a, + lipoprotein + -aemia, blood (05 Mar 2000) |